Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IMI Intelligent Medical Implants AG

www.intmedimplants.com

Latest From IMI Intelligent Medical Implants AG

LambdaVision Inc.

Artificial retinal prostheses are poised to make a dramatic impact by restoring at least partial vision to people blinded by degenerative ophthalmic diseases. A number of companies are developing complex implantable microelectronic innovations, many with external hardware components, to stimulate the retina and overcome the photoreceptor cell deterioration that is the hallmark of these diseases. LambdaVision Inc. is taking a unique approach to restoring vision by developing a flexible, protein-based retinal implant designed to provide higher resolution and to be less surgically invasive than competing technologies.

Medical Device

Recent Financings of Private Companies (12/2006)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Neurostimulation's Billion-Dollar Markets

Beyond the functional stimulation of muscles to get them moving, electrical stimulation can also operate on blood vessels, membranes, and receptors-targets in the body once regarded as the domain of pharmaceuticals. Indeed, driving sales of $2 billion in the neurostimulation industry in 2005 and growth rates of almost 20% going forward, are large-market clinical indications that haven't been well-served by drugs: pain, epilepsy, depression, stroke, urinary incontinence, Parkinson's disease, and obsessive-compulsive disorder. For some of these disorders, chronic neurostimulation-of the deep brain, the spinal cord, the vagus and other nerves-promises site-specific, side-effect free and reversible therapies that have the potential to be efficacious where drugs can't.
Medical Device

IMI Intelligent Medical Implants AG

Intelligent Medical Implants is one of a select group of companies, along with Optobionics and Second Sight Medical Products, developing a retinal implant. It sees itself as the leader, having implanted the first completely wireless retinal prosthesis in four patients with more than six months of follow-up.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • IMI Intelligent Medical Implants AG
  • Senior Management
  • Robert J Rosenthal, PhD, CEO
  • Contact Info
  • IMI Intelligent Medical Implants AG
    Phone: (41) 41 723 3838
    Gotthardstrasse 3
    Zug, CH 6304
    Switzerland
UsernamePublicRestriction

Register